![image](http://assets.medpagetoday.net/media/images/95xxx/95086_m.jpg)
Meeting Coverage >
ECTRIMS
![image](http://assets.medpagetoday.net/media/images/95xxx/95086_m.jpg)
![image](http://assets.medpagetoday.net/media/images/95xxx/95054_m.jpg)
![image](http://assets.medpagetoday.net/media/images/88xxx/88842_m.jpg)
![image](http://assets.medpagetoday.net/media/images/88xxx/88838_m.jpg)
![image](http://assets.medpagetoday.net/media/images/88xxx/88613_m.jpg)
![image](http://assets.medpagetoday.net/media/images/88xxx/88591_m.jpg)
![image](http://assets.medpagetoday.net/media/images/88xxx/88590_m.jpg)
![image](http://assets.medpagetoday.net/media/images/82xxx/82188_m.jpg)
![image](http://assets.medpagetoday.net/media/images/82xxx/82170_m.jpg)
![image](http://assets.medpagetoday.net/media/images/82xxx/82125_m.jpg)
![image](http://assets.medpagetoday.net/media/images/82xxx/82096_m.jpg)
![image](http://assets.medpagetoday.net/media/images/68xxx/68835_m.jpg)
![image](http://assets.medpagetoday.net/media/images/68xxx/68804_m.jpg)
![image](http://assets.medpagetoday.net/media/images/60xxx/60307_m.jpg)
Generic Copaxone for MS Passes Clinical Test
BOSTON -- A copycat version of the multiple sclerosis drug Copaxone, known generically as glatiramer acetate, performed similarly to the original product in a head-to-head trial, paving the way for it to win regulatory approval as a generic drug.
Sep 12, 2014
Novel Drug Beats Avonex for MS Efficacy; Safety Still a Worry
BOSTON -- Daclizumab HYP cut relapse rates and disability progression in multiple sclerosis patients more effectively than interferon beta-1a (Avonex) in a phase III trial, but liver toxicity with the IL-2 inhibitor reared its head again.
Sep 12, 2014